Insiders Trades
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 22 Sept 2026 for ELI LILLY & Co, €4,316. Read the official filing
Filing timeline
BuySaleGabrielle Sulzberger
Insider track record
Disclosed buys
2
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+52.0%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Gabrielle Sulzberger: trading record in brief
Gabrielle Sulzberger is a declared insider at 5 companies (board member); the most frequent names are ELI LILLY & Co, Cerevel Therapeutics Holdings, Inc. and Mastercard Inc. The record holds 74 filings, for trades running from 1 June 2021 to 21 September 2026.
The open-market record is one-sided, with 2 purchases worth €295k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 68 share grants and 3 option exercises.
The latest filing, published on 22 September 2026, reports a share grant of €4,316 in ELI LILLY & Co. The clock since the last published purchase (12 August 2025) now reads 432 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Gabrielle Sulzberger
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations74 total
4.257 shares@ US$1,164.89Common StockSEC:0001262388-26-000018:0
4.191 shares@ US$1,183.160.0000% mcap0.7% of flowCommon StockSEC:0001262388-26-000016:0
4.323 shares@ US$1,146.900.0000% mcap0.8% of flowCommon StockSEC:0001262388-26-000014:0
4.39 sharesCommon StockSEC:0001262388-26-000012:0
5.39 shares@ US$919.900.0000% mcap0.7% of flowCommon StockSEC:0001262388-26-000008:0
5.013 shares@ US$989.120.8% of flowCommon StockSEC:0001262388-26-000006:0
4.786 shares@ US$1,036.050.7% of flowCommon StockSEC:0001262388-26-000004:0
4.762 shares@ US$1,041.290.8% of flowCommon StockSEC:0001262388-26-000002:0
4.668 shares@ US$1,062.190.8% of flowCommon StockSEC:0001262388-25-000010:0
4.853 shares@ US$1,021.700.8% of flowCommon StockSEC:0001262388-25-000008:0
6.129 shares@ US$808.960.8% of flowCommon StockSEC:0001262388-25-000006:0
6.627 shares@ US$748.190.8% of flowCommon StockSEC:0001262388-25-000004:0
7.103 shares@ US$698.050.8% of flowCommon StockSEC:0000059478-25-000232:0
117 shares@ US$641.18212.1% of flowCommon StockSEC:0000059478-25-000212:0
Canonical exit: 10 Nov 2025 (T+90)
6.505 shares@ US$762.180.7% of flowCommon StockSEC:0000059478-25-000194:0
458 shares0Class A Common StockSEC:0001141391-25-000150:0
6.14 shares@ US$807.580.9% of flowCommon StockSEC:0000059478-25-000176:0
6.566 shares@ US$755.110.7% of flowCommon StockSEC:0000059478-25-000154:0
6.061 shares@ US$818.020.7% of flowCommon StockSEC:0000059478-25-000124:0
6.012 shares@ US$824.760.7% of flowCommon StockSEC:0000059478-25-000103:0
5.784 shares@ US$857.200.8% of flowCommon StockSEC:0000059478-25-000077:0
6.679 shares@ US$742.350.8% of flowCommon StockSEC:0000059478-25-000016:0
12.73 shares@ US$779.001.5% of flowCommon StockSEC:0000059478-24-000291:0
13.637 shares@ US$727.201.5% of flowCommon StockSEC:0000059478-24-000276:0
11 shares@ US$906.131.5% of flowCommon StockSEC:0000059478-24-000238:0
25 of 74 declarations
